Rocket Lab stock climbed 9% on Friday as Wall Street set a $232 million target for second-quarter revenue. That figure would mark about 60% growth from a year earlier and puts the business under a blunt test: can rapid expansion keep outrunning losses?
Investors in Rocket Lab get the answer after the market closes on Monday, Aug. 10. The report will show whether management can stay near its own May guide of $225 million to $240 million in revenue while continuing to narrow the gap between growth and profitability.
Rocket Lab and $232 million revenue
$232 million is the number that matters most going into the print. It sits inside management’s $225 million to $240 million range and slightly above the midpoint, which would imply roughly 61% growth from the $144 million Rocket Lab booked a year earlier.
$200 million was the company’s opening-quarter revenue for 2026, extending a run that moved from $144 million to $155 million, then to $180 million, and then to that $200 million mark, with each quarter setting a record. The setup suggests investors are not just looking for another beat; they are looking for proof that the record streak still has room to run.
Rocket Lab backlog and liquidity
$2.2 billion in backlog ended the first quarter, alongside access to more than $2 billion in total liquidity. Rocket Lab also signed 31 new Electron and HASTE launch contracts and five dedicated Neutron missions, while the manifest passed 70 contracted missions.
63.5% year-over-year revenue growth in the first quarter gave Wall Street reason to raise the bar, and the company beat every metric it had guided to, including margins and adjusted EBITDA (earnings before interest, taxes, depreciation, amortization). The second-quarter guide calls for GAAP gross margins of 33% to 35% and an adjusted EBITDA loss of $20 million to $26 million, which means scale is still arriving faster than profits.
Space Force awards after June 30
$663 million in Space Force awards landed after the quarter closed on June 30, including a $266 million missile-defense deal announced on July 27 and a $397 million award received on Aug. 4. The July 27 contract covers 12 suborbital launches with up to six more as options, and the Aug. 4 award is for the SB-AMTI airborne-threat-tracking program.
Those awards are material for the next reporting period, not this one, because both arrived after June 30 and backlog excludes unexercised options. The SB-AMTI work also leans on Neutron, which has never flown, so the next real test is not whether Rocket Lab can sign more business but how fast it can turn those signed deals into booked revenue.
$183 million in losses over the past 12 months still hangs over the equity, even after the recent share move and a valuation above $50 billion. Rocket Lab is trading at more than 70 times the roughly $680 million in revenue it has booked over the past 12 months, so this report needs more than growth: it needs evidence that the path to less red ink is still intact.
